A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Coombes, R Charles; Hall, Emma; Gibson, Lorna J; Paridaens, Robert; Jassem, Jacek; Delozier, Thierry; Jones, Stephen E; Alvarez, Isabel; Bertelli, Gianfilippo; Ortmann, Olaf; +17 more... Coates, Alan S; Bajetta, Emilio; Dodwell, David; Coleman, Robert E; Fallowfield, Lesley J; Mickiewicz, Elizabeth; Andersen, Jorn; Lønning, Per E; Cocconi, Giorgio; Stewart, Alan; Stuart, Nick; Snowdon, Claire F; Carpentieri, Marina; Massimini, Giorgio; Bliss, Judith M; van de Velde, Cornelius; Intergroup Exemestane Study; (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. The New England journal of medicine, 350 (11). pp. 1081-1092. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa040331

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1056/NEJMoa040331

Abstract

Share

Download

Filename: nejmoa040331.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar